Search research articles
Contact Us
Filters
Showing results (1-10 of 142) with videos related to
Page
of 15
Sort By:
Current Topics in Medicinal Chemistry
|
September 17, 2009
Structure- and ligand-based drug design: advances and perspectives
Adriano D Andricopulo
Current Pharmaceutical Design
|
May 22, 2013
Structure-based drug design to overcome drug resistance: challenges and opportunities
Rafaela S Ferreira, Adriano D Andricopulo
Current Topics in Medicinal Chemistry
|
February 28, 2017
From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery
Leonardo G Ferreira, Adriano D Andricopulo
Future Medicinal Chemistry
|
October 23, 2013
Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition
Leonardo G Ferreira, Adriano D Andricopulo
Drug Discovery Today
|
July 2, 2016
Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective
Leonardo G Ferreira, Adriano D Andricopulo
Pharmacology & Therapeutics
|
June 6, 2017
Targeting cysteine proteases in trypanosomatid disease drug discovery
Leonardo G Ferreira, Adriano D Andricopulo
Future Medicinal Chemistry
|
July 12, 2023
Empowering neglected tropical disease drug discovery with translational medicinal chemistry
Leonardo Lg Ferreira, Adriano D Andricopulo
Mini Reviews in Medicinal Chemistry
|
June 25, 2005
Structure-activity relationships for the design of small-molecule inhibitors
Adriano D Andricopulo, Carlos A Montanari
Bioorganic & Medicinal Chemistry Letters
|
March 20, 2012
Consensus hologram QSAR modeling for the prediction of human intestinal absorption
Tiago L Moda, Adriano D Andricopulo
Molecular Diversity
|
February 3, 2009
Fragment-based QSAR: perspectives in drug design
Lívia B Salum, Adriano D Andricopulo
Page
of 15
Search research articles
Search
Showing results (1-10 of 142) with videos related to
Sort By:
Page
of 15
Current Topics in Medicinal Chemistry
|
September 17, 2009
Structure- and ligand-based drug design: advances and perspectives
Adriano D Andricopulo
Current Pharmaceutical Design
|
May 22, 2013
Structure-based drug design to overcome drug resistance: challenges and opportunities
Rafaela S Ferreira, Adriano D Andricopulo
Current Topics in Medicinal Chemistry
|
February 28, 2017
From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery
Leonardo G Ferreira, Adriano D Andricopulo
Future Medicinal Chemistry
|
October 23, 2013
Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition
Leonardo G Ferreira, Adriano D Andricopulo
Drug Discovery Today
|
July 2, 2016
Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective
Leonardo G Ferreira, Adriano D Andricopulo
Pharmacology & Therapeutics
|
June 6, 2017
Targeting cysteine proteases in trypanosomatid disease drug discovery
Leonardo G Ferreira, Adriano D Andricopulo
Future Medicinal Chemistry
|
July 12, 2023
Empowering neglected tropical disease drug discovery with translational medicinal chemistry
Leonardo Lg Ferreira, Adriano D Andricopulo
Mini Reviews in Medicinal Chemistry
|
June 25, 2005
Structure-activity relationships for the design of small-molecule inhibitors
Adriano D Andricopulo, Carlos A Montanari
Bioorganic & Medicinal Chemistry Letters
|
March 20, 2012
Consensus hologram QSAR modeling for the prediction of human intestinal absorption
Tiago L Moda, Adriano D Andricopulo
Molecular Diversity
|
February 3, 2009
Fragment-based QSAR: perspectives in drug design
Lívia B Salum, Adriano D Andricopulo
Page
of 15